These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12647214)

  • 1. Prognostic value of immunocytochemical determination of parathyroid hormone-related peptide expression in cells of mammary ductal carcinoma. Analysis of 7 years of the disease course.
    Surowiak P; Dziegiel P; Matkowski R; Sopel M; Wojnar A; Kornafel J; Zabel M
    Virchows Arch; 2003 Mar; 442(3):245-51. PubMed ID: 12647214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases.
    Kohno N; Kitazawa S; Fukase M; Sakoda Y; Kanbara Y; Furuya Y; Ohashi O; Ishikawa Y; Saitoh Y
    Surg Today; 1994; 24(3):215-20. PubMed ID: 8003863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the parathyroid hormone-related protein expression in breast carcinoma.
    Yoshida A; Nakamura Y; Shimizu A; Harada M; Kameda Y; Nagano A; Inaba M; Asaga T
    Breast Cancer; 2000; 7(3):215-20. PubMed ID: 11029801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical evaluation of metallothionein (MT) expression in myoepithelial cells of ductal mammary carcinoma and its relation to survival time: analysis of 7-year course of the disease.
    Surowiak P; Dziegiel P; Matkowski R; Kornafel J; Wojnar A; Zabe M
    Folia Histochem Cytobiol; 2002; 40(2):199-200. PubMed ID: 12056644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival.
    Linforth R; Anderson N; Hoey R; Nolan T; Downey S; Brady G; Ashcroft L; Bundred N
    Clin Cancer Res; 2002 Oct; 8(10):3172-7. PubMed ID: 12374685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome.
    Xu C; Wang Z; Cui R; He H; Lin X; Sheng Y; Zhang H
    BMC Cancer; 2015 Nov; 15():925. PubMed ID: 26597083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue.
    Downey SE; Hoyland J; Freemont AJ; Knox F; Walls J; Bundred NJ
    J Pathol; 1997 Oct; 183(2):212-7. PubMed ID: 9390035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive production of parathyroid hormone-related protein (PTHrP) by fibroblasts derived from normal and pathological human breast tissue.
    Cros M; Cataisson C; Cho YM; Berthois Y; Bernard-Poenaru O; Denne M; Graulet AM; De Vernejoul MC; Foley J; Bouizar Z
    Oncol Res; 2002; 13(3):137-46. PubMed ID: 12549623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of parathyroid hormone-related protein and its receptor in breast carcinoma: a potential autocrine effector system.
    Iezzoni JC; Bruns ME; Frierson HF; Scott MG; Pence RA; Deftos LJ; Bruns DE
    Mod Pathol; 1998 Mar; 11(3):265-70. PubMed ID: 9521473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.
    Burkhardt M; Mayordomo E; Winzer KJ; Fritzsche F; Gansukh T; Pahl S; Weichert W; Denkert C; Guski H; Dietel M; Kristiansen G
    J Clin Pathol; 2006 Apr; 59(4):403-9. PubMed ID: 16484444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases.
    Bouizar Z; Spyratos F; Deytieux S; de Vernejoul MC; Jullienne A
    Cancer Res; 1993 Nov; 53(21):5076-8. PubMed ID: 8221637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
    Fleming NI; Trivett MK; George J; Slavin JL; Murray WK; Moseley JM; Anderson RL; Thomas DM
    Cancer Res; 2009 Sep; 69(18):7473-9. PubMed ID: 19723659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistological evaluation of parathyroid hormone-related protein in breast cancer with and without calcification on mammography].
    Kanbara Y; Kono N; Nakaya M; Ishikawa Y; Fujiwara O; Kitazawa R; Kitazawa S
    Nihon Geka Gakkai Zasshi; 1993 Apr; 94(4):394-9. PubMed ID: 8321185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.
    Xiao J; Zhou Y; Zhu W
    Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone related protein in breast cancers of widely varying prognosis.
    Kissin MW; Henderson MA; Danks JA; Hayman JA; Bennett RC; Martin TJ
    Eur J Surg Oncol; 1993 Apr; 19(2):134-42. PubMed ID: 8491317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease.
    Surowiak P; Dziegiel P; Zabel M; Matkowski R; Kornafel J
    Folia Histochem Cytobiol; 2001; 39(2):143-4. PubMed ID: 11374797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
    Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
    Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistologic evaluation of parathyroid hormone-related protein in human lung cancer and normal tissue with newly developed monoclonal antibody.
    Kitazawa S; Fukase M; Kitazawa R; Takenaka A; Gotoh A; Fujita T; Maeda S
    Cancer; 1991 Feb; 67(4):984-9. PubMed ID: 1991268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.